[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Reiter RJ, Sharma R, Cucielo MSmaniotto, Tan DXian, Rosales-Corral S, Gancitano G, Chuffa LGustavo de. Brain washing and neural health: role of age, sleep, and the cerebrospinal fluid melatonin rhythm. Cell Mol Life Sci. 2023;80(4):88.
Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V, et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 2021.
Rejeski K, Burchert A, Iacoboni G, Sesques P, Fransecky L, Buecklein V, Trenker C, Hernani R, Naumann R, Schäfer JA, et al. Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy. Blood Adv. 2022.
Rejeski K, Hansen DK, Bansal R, Sesques P, Ailawadhi S, Logue JM, Bräunlein E, Santos DMCordas D, Freeman CL, Alsina M, et al. The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma. J Hematol Oncol. 2023;16(1):88.
Rejeski K, Perez A, Iacoboni G, Blumenberg V, Bücklein VL, Völkl S, Penack O, Albanyan O, Stock S, Müller F, et al. Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion. Sci Adv. 2023;9(38):eadg3919.
Rejon C, Al-Masri M, McCaffrey L. Cell Polarity Proteins in Breast Cancer Progression. J Cell Biochem. 2016.
Rekhtman N, Montecalvo J, Chang JC, Alex D, Ptashkin RN, Ai N, Sauter JL, Kezlarian B, Jungbluth A, Desmeules P, et al. Thoracic SMARCA4-deficient sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas. J Thorac Oncol. 2019.
Rekittke NE, Ang M, Rawat D, Khatri R, Linn T. Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells. Stem Cells Int. 2016;2016:3764681.
Relaño-Ginés A, Lehmann S, Crozet C. Prion diseases and adult neurogenesis: How do prions counteract the brain's endogenous repair machinery?. Prion. 2014;8(3):240-246.
Relaño-Ginés A, Lehmann S, Crozet C. Cell-based therapy against prion diseases. Curr Opin Pharmacol. 2018;44:8-14.
Remark LH, Leclerc K, Ramsukh M, Lin Z, Lee S, Dharmalingam B, Gillinov L, Nayak VV, Parente PEl, Sambon M, et al. Loss of Notch signaling in skeletal stem cells enhances bone formation with aging. Bone Res. 2023;11(1):50.
Reményi P, Gopcsa L, Marton I, Réti M, Mikala G, Pető M, Barta A, Bátai A, Farkas Z, Borbényi Z, et al. Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF. Adv Ther. 2014.
Remes K, Anttila P, Silvennoinen R, Putkonen M, Ollikainen H, Terävä V, Sinisalo M, Kananen K, Schain F, Castren-Kortegangas P, et al. Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013. PLoS One. 2018;13(12):e0208507.
Remke M, Hering E, Gerber NU, Kool M, Sturm D, Rickert CH, Gerß J, Schulz S, Hielscher T, Hasselblatt M, et al. Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma. Childs Nerv Syst. 2013.
Remley VAnn, Collins A, Underwood S, Jin J, Kim Y, Cai Y, Prochazkova M, Moses L, Byrne KM, Jin P, et al. Optimizing a fully automated and closed system process for red blood cell reduction of human bone marrow products. Cytotherapy. 2023.
Rempel SK, Welch MJ, Ludwig AL, M Phillips J, Kancherla Y, Zack DJ, Gamm DM, Gómez TM. Human photoreceptors switch from autonomous axon extension to cell-mediated process pulling during synaptic marker redistribution. Cell Rep. 2022;39(7):110827.
Remy S, Solis D, Silland P, Neyts J, Roussi F, Touboul D, Litaudon M. Isolation of phenanthrenes and identification of phorbol ester derivatives as potential anti-CHIKV agents using FBMN and NAP from Sagotia racemosa. Phytochemistry. 2019;167:112101.
Remya NS, Syama S, Gayathri V, Varma HK, Mohanan PV. Corrigendum to "An in vitro study on the interaction of hydroxyapatite nanoparticles and bone marrow mesenchymal stem cells for assessing the toxicological behaviour" [Colloids Surf. B: Biointerfaces 117 (2014) 389-397]. Colloids Surf B Biointerfaces. 2021;207:112000.
Ren F, Sheng W-Q, Du X. CD133: A cancer stem cells marker, is used in colorectal cancers. World J Gastroenterol. 2013;19(17):2603-2611.
Ren K-Q, Cao X-Z, Liu Z-H, Guo H, Quan M-F, Liu F, Jiang L, Xiang H-L, Deng X-Y, Cao J-G. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling. Int J Oncol. 2013.
Ren N, Li J, Qiu J, Sang Y, Jiang H, Boughton RI, Huang L, Huang W, Liu H. Nanostructured Titanate with Different Metal Ions on the Surface of Metallic Titanium: A Facile Approach for Regulation of rBMSCs Fate on Titanium Implants. Small. 2014.
Ren CFang, Sun HYan, Wang LZhong, Zhang GMin, Fan YXuan, Yan GYao, Wang D, Wang F. Reprogramming mechanism and genetic stability of induced pluripotent stem cells (iPSCs). Yi Chuan. 2014;36(9):879-887.
Ren W, Zhang Y, Li M, Wu L, Wang G, Baeg G-H, You J, Li Z, Lin X. Windpipe Controls Drosophila Intestinal Homeostasis by Regulating JAK/STAT Pathway via Promoting Receptor Endocytosis and Lysosomal Degradation. PLoS Genet. 2015;11(4):e1005180.
Ren Y-B, Huang J-H, Cai W-J, Shen Z-Y. Shen-Jing as a Chinese medicine concept might be a counterpart of stem cells in regenerative medicine. Chin J Integr Med. 2015.
Ren G, Esposito M, Kang Y. Bone metastasis and the metastatic niche. J Mol Med (Berl). 2015.